Thus, transgenic shutdown in symptomatic mice by doxycycline administration leads to normal GSK-3 activity, normal levels of phospho-tau, decreased neuronal death, and suppression of cognitive deficits, thereby further supporting the potential of inhibitors of GSK-3 in AD (Engel et al., 2006b). This evidence concerns the gene MAPT and Cognitive impairment.